Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas

被引:0
|
作者
Tasneem Motiwala
Kalpana Ghoshal
Anindita Das
Sarmila Majumder
Dieter Weichenhan
Yue-Zhong Wu
Kristen Holman
S Jill James
Samson T Jacob
Christoph Plass
机构
[1] The Ohio State University,Department of Molecular and Cellular Biochemistry
[2] Medizinische Universität zu Lübeck,Division of Human Cancer Genetics
[3] Institut für Biologie,Division of Biochemical Toxicology
[4] Ratzeburger Allee 160,Division of Cardiology, Department of Internal Medicine
[5] College of Medicine,undefined
[6] The Ohio State University,undefined
[7] Food and Drug administration,undefined
[8] National Center for Toxicological Research,undefined
[9] Virginia Commonwealth University,undefined
来源
Oncogene | 2003年 / 22卷
关键词
DNA methylation; DNA amplification; folate deficiency; hepatocellular carcinoma; PTPRO; 5-azacytidine;
D O I
暂无
中图分类号
学科分类号
摘要
A diet lacking folic acid and choline and low in methionine (folate/methyl deficient diet, FMD diet) fed to rats is known to produce preneoplastic nodules (PNNs) after 36 weeks and hepatocellular carcinomas (tumors) after 54 weeks. FMD diet-induced tumors exhibit global hypomethylation and regional hypermethylation. Restriction landmark genome scanning analysis with methylation-sensitive enzyme NotI (RLGS-M) of genomic DNA isolated from control livers, PNNs and tumor tissues was performed to identify the genes that are differentially methylated or amplified during multistage hepatocarcinogenesis. Out of the 1250 genes analysed, 2 to 5 genes were methylated in the PNNs, whereas 5 to 45 genes were partially or completely methylated in the tumors. This analysis also showed amplification of 3 to 12 genes in the primary tumors. As a first step towards identifying the genes methylated in the PNNs and primary hepatomas, we generated a rat NotI–EcoRV genomic library in the pBluescriptKS vector. Here, we describe identification of one methylated and downregulated gene as the rat protein tyrosine phosphatase receptor type O (PTPRO) and one amplified gene as rat C-MYC. Methylation of PTPRO at the NotI site located immediate upstream of the trancription start site in the PNNs and tumors, and amplification of C-MYC gene in the tumors were confirmed by Southern blot analyses. Bisulfite genomic sequencing of the CpG island encompassing exon 1 of the PTPRO gene revealed dense methylation in the PNNs and tumors, whereas it was methylation free in the livers of animals on normal diet. Reverse transcription–polymerase chain reaction (RT–PCR) analysis showed significant decrease in the expression of PTPRO in the tumors and in a transplanted rat hepatoma. The expression of PTPRO mRNA in the transplanted hepatoma after demethylation with 5-azacytidine, a potent inhibitor of DNA methyltransferases, further confirmed the role of methylation in PTPRO gene expression. These results demonstrate alteration in methylation profile and expression of specific genes during tumor progression in the livers of rats in response to folate/methyl deficiency, and further implicate the potential role of PTPRO as a novel growth regulatory gene at least in the hepatocellular carcinomas.
引用
收藏
页码:6319 / 6331
页数:12
相关论文
共 50 条
  • [21] RETRACTION: Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer (Retraction of Vol 101, Pg 13844, 2004)
    Motiwala, Tasneem
    Kutay, Huban
    Ghoshal, Kalpana
    Bai, Shoumei
    Seimiya, Hiroyuki
    Tsuruo, Takashi
    Suster, Saul
    Morrison, Carl
    Jacob, Samson T.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (19)
  • [22] Protein tyrosine phosphatase receptor type O (PTPRO) knockdown enhances the proliferative, invasive and angiogenic activities of trophoblast cells by suppressing ER resident protein 44 (ERp44) expression in preeclampsia
    Yang, Yang
    Qiu, Xiaoxia
    Wang, Fang
    BIOENGINEERED, 2021, 12 (02) : 9561 - 9574
  • [23] Protein tyrosine phosphatase receptor type delta (PTPRD) gene in an animal model of restless legs syndrome
    Morais, Milca Abda
    Franco, Beatriz Silva
    Holanda, Alessandro Spencer Souza
    de Paula Simino, Lais Angelica
    Veras, Alana Carolina Costa
    Torsoni, Marcio Alberto
    Manconi, Mauro
    Torsoni, Adriana Souza
    Esteves, Andrea Maculano
    JOURNAL OF SLEEP RESEARCH, 2023, 32 (02)
  • [24] Proteolytic processing of protein-tyrosine phosphatase receptor type Z
    Fujikawa, Akihiro
    Chow, Jeremy P. H.
    Shimizu, Hidetada
    Suzuki, Ryoko
    Noda, Masaharu
    NEUROSCIENCE RESEARCH, 2009, 65 : S83 - S83
  • [25] miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F
    Ye, Xiangyang
    Qiu, Rongxian
    He, Xiongzhi
    Hu, Zhengting
    Zheng, Fengfeng
    Huang, Xiaogang
    Xie, Xuemei
    Chen, Feihua
    Ou, Hangbing
    Lin, Guoxian
    BIOENGINEERED, 2022, 13 (01) : 1090 - 1102
  • [26] Suppression of insulin receptor activation by overexpression of the protein tyrosine phosphatase LAR in hepatoma cells
    Li, PM
    Zhang, WR
    Goldstein, BJ
    CELLULAR SIGNALLING, 1996, 8 (07) : 467 - 473
  • [27] Suppression of the protein tyrosine phosphatase LAR decreases the rate of insulin receptor dephosphorylation.
    Mooney, RA
    Kulas, DT
    Novak, JS
    DIABETES, 1996, 45 : 660 - 660
  • [28] RNA interference targeting protein tyrosine phosphatase ζ receptor-type protein tyrosine phosphatase β suppresses glioblastoma growth in vitro and in vivo
    Ulbricht, Ulrike
    Eckerich, Carmen
    Fillbrandt, Regina
    Westphal, Manfred
    Lamszus, Katrin
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 (05) : 1497 - 1506
  • [29] RETRACTED: Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer (Retracted article. See vol. 119, 2022)
    Motiwala, T
    Kutay, H
    Ghoshal, K
    Bai, SM
    Seimiya, H
    Tsuruo, T
    Suster, S
    Morrison, C
    Jacob, ST
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (38) : 13844 - 13849
  • [30] CpG Methylation Status Changes Within the Protein Tyrosine Phosphatase Non-Receptor Type 22 Gene Promoters in Children and Adolescents of Greek Origin with Type 1 Diabetes
    Mouzaki, Konstantina
    Giza, Styliani
    Kotanidou, Eleni P.
    Fragou, Aikaterini
    Taousani, Maria
    Eboriadou-Petikopoulou, Maria
    Tzimagiorgis, Georgios
    Galli-Tsinopoulou, Assimina
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 210 - 211